Investing News NetworkFebruary 27, 2025Radiopharm Theranostics (RAD:AU) has announced Half Year Report and Appendix 4D 31 December 2024Download the PDF here.
Investing News Network29 August 2025 Appendix 4E and Preliminary Final Report Radiopharm Theranostics (RAD:AU) has announced Appendix 4E and Preliminary Final ReportDownload the PDF here. Keep Reading...
Investing News Network29 July 2025 Quarterly Activities/Appendix 4C Cash Flow Report Radiopharm Theranostics (RAD:AU) has announced Quarterly Activities/Appendix 4C Cash Flow ReportDownload the PDF here. Keep Reading...
Investing News Network27 July 2025 RAD receives IND approval from US FDA for Betabart (RV-01) Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)Download the PDF here. Keep Reading...
Investing News Network10 June 2025 RAD Granted US FDA Fast Track for RAD101 Metastases Imaging Radiopharm Theranostics (RAD:AU) has announced RAD Granted US FDA Fast Track for RAD101 Metastases ImagingDownload the PDF here. Keep Reading...
Investing News Network03 June 2025 RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202Download the PDF here. Keep Reading...
LAURION Reports Wide Mineralized Zones and High-Grade Polymetallic Intercepts from LBX25-097 and LBX25-100, Advancing Structural Continuity at Ishkoday 3h
precious-metals-investing LAURION Reports Wide Mineralized Zones and High-Grade Polymetallic Intercepts from LBX25-097 and LBX25-100, Advancing Structural Continuity at Ishkoday 3h
base-metals-investing Questcorp Mining Engages Contractor for Commencement of North Island Copper IP Survey 5h
silver-investing Nine Mile Metals: Advancing Copper-rich Critical Mineral Projects in Canada’s Bathurst Mining Camp 13h